The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...
InvestorsHub on MSN
Aldeyra receives FDA rejection for dry eye treatment reproxalap
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) said it has received a Complete Response Letter from the U.S. Food and Drug ...
From the start of my career, I have approached dry eye disease (DED) with an interventional, science-based strategy. For too long, DED was not treated as a true disease, with little interest or ...
HOUSTON, TX, UNITED STATES, February 12, 2026 /EINPresswire.com/ — From classrooms and conference rooms to living rooms and daily commutes, screens now dominate ...
NEW early-phase clinical data suggest that eye drops derived from umbilical cord mesenchymal stem cells (MSCs) may offer a novel treatment option for patients with refractory dry eye disease (DED), ...
A new kind of eye care has arrived on the Main Line, blending medical treatment with spa-style rejuvenation, writes Timothy Alexander for MyChesCo. See La Vie Eyecare & Eyewear has opened its doors in ...
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat ...
Amazing, fantastic results, and pure amazement — that’s how Dr. Arthur Benjamin of the Benjamin Eye Institute describes what he’s seeing from patients after incorporating Tixel i® treatments for dry ...
Please provide your email address to receive an email when new articles are posted on . Once upon a time, dry eye disease was simple. Like a desert, an eye with dry eye disease (DED) simply had too ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results